中国科技论文统计源期刊 中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库(JST)
第七届湖北十大名刊提名奖  
医药导报, 2019, 38(1): 71-74
doi: 10.3870/j.issn.1004-0781.2019.01.016
吻合器痔上黏膜环切术后不同镇痛模式的效果比较
Clinical Comparison of Different Analgesia Methods After Surgery in Patients Undergoing Procedure for Prolapse and Hemorrhoids
孔亮1,, 孟秀荣1,, 陈永军1, 李德刚1, 李桂英1, 张建林1, 纪伟1, 周洪2

摘要:

目的 比较不同镇痛模式在吻合器痔上黏膜环切(PPH)术后镇痛中的效果。方法 选择拟于腰硬联合麻醉下择期行PPH术患者60例,完全随机均分为静脉自控镇痛(PCIA)组与硬膜外自控镇痛(PCEA)组,每组30例。PCIA组:舒芬太尼100 μg+托烷司琼10 mg+0.9%氯化钠注射液至100 mL术后静脉注射,背景输入剂量为2 mL·h-1,单次PCA量为1 mL,间隔时间15 min;PCEA组:0.179%甲磺酸罗哌卡因+舒芬太尼40 μg+0.9%氯化钠注射液至200 mL术后硬膜外注射,背景输入剂量4 mL·h-1,单次PCA量为2 mL,间隔时间15 min,每日静脉注射托烷司琼5 mg。观察并记录术后6,12,24,48 h的Ramsay镇静评分、视觉模拟疼痛(VAS)评分、舒适评分(BCS)、改良Bromage分级。记录PCA 24,48 h内实际按压次数和有效按压次数。记录术后并发症发生情况。结果 术后12,24 h时,PCIA组Ramsay镇静评分、VAS评分明显高于PCEA组,BCS评分明显低于PCEA组(P<0.05);术后6 h时,PCIA组Bromage分级明显低于PCEA组(P<0.05)。术后24,48 h PCIA组实际按压次数、有效按压次数明显多于PCEA组(P<0.05)。 PCIA组发生术后恶心、呕吐5例,明显多于PCEA组(P<0.05)。结论 PCEA用于PPH术后镇痛,可提供良好的舒适度,优于PCIA。

关键词: 舒芬太尼 ; 罗哌卡因 ; 甲磺酸 ; 镇痛 ; 术后 ; 静脉自控镇痛 ; 硬膜外自控镇痛 ; 痔上黏膜环切术

Abstract:

Objective To evaluate the different analgesia mode for pain control in patients who undergo a procedure for prolapse and hemorrhoids. Methods Sixty patients who were undergoing the procedure for prolapse and hemorrhoids with combined spinal epidural anesthesia were randomized into two groups (30 patients each group). Group PCIA had the patient-controlled intravenous analgesia with sufentanil 100 μg and tropisetron 10 mg with 0.9% sodium chloride soution to 100 mL, the input background dose was 2 mL·h-1, the single PCA was 1 mL, the time interval was 15 min. Group PCEA had the patient-controlled epidural analgesia with 0.179% ropivacaine mesylate and sufentanil 40 μg with 0.9% sodium chloride soution to 200 mL, the input background dose was 4 mL·h-1, the single PCA was 2 mL, the time interval was 15 min, daily intravenous administration of tropisetron 5 mg. Recorded the Ramsay sedation score (RSS), the visual analogue scale (VAS), the comfortable satisfaction score (BCS) well as the improved Bromage classification at 6, 12, 24 and 48 hours after surgery. The frequencies of actual and effective pressing were also observed at the time point of 24 and 48 hours after surgery. Postoperative complications, including pruritus, nausea, headaches, and urinary retention, were also recorded. Results Compare to group PCEA, the Ramsay sedation score and the VAS score were significantly higher and the comfortable satisfaction score was significantly lower in group PCIA at 12, 24 h after the surgery(P<0.05), the improved Bromage classification was significantly lower in group PCIA at 6 h after the surgery(P<0.05). At the time of 24, 48 h after the operation, the frequencies of actual and effective pressing were significantly higher in group PCIA than those in group PCEA(P<0.05). Complications were more common in group PCIA, five patients presented postoperative nausea and vomiting(P<0.05). Conclusion The PCEA could provide more comfortable better postoperative analgesia and more comfortable than the PCIA for patients undergoing the procedure for prolapse and hemorrhoids.

Key words: Sufentanil ; Ropivacaine mesylate ; Analgesia ; postoperative ; Patient-controlled intravenous analgesia ; Patient-controlled epidural analgesia ; Procedure for prolapse and hemorrhoids

吻合器痔上黏膜环切术(procedure for prolapse and hemorrhoids,PPH)作为治疗Ⅲ、Ⅳ度内痔和混合痔的重要手段已广泛应用于临床,如何减轻术后疼痛成为PPH推广的重要环节,故采取安全有效的术后镇痛尤为重要。静脉自控镇痛(patient controlled intravenous analgesia,PCIA)和硬膜外自控镇痛(patient-controlled epidural analgesia,PCEA)是临床常用的患者自控镇痛(patient controlled analgesia,PCA)模式。2015年6月—2016年8月,笔者观察不同镇痛模式在经吻合器痔上黏膜环切术后镇痛的应用,为临床提供参考。

1 资料与方法
1.1 一般资料

本研究经我院伦理委员会同意,患者及家属签署知情同意书。选择拟于腰硬联合麻醉下择期行PPH术患者60例,男女不限,年龄20~60岁,体质量指数18~25 kg·(m2)-1,美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级为Ⅰ或Ⅱ级。根据术后不同镇痛模式,完全随机均分为PCIA组与PCEA组,每组30例。均无严重系统性疾病,无长期使用镇静药及阿片类药物等,精神、智力、听力正常。排除椎管内肿瘤、穿刺部位感染、近期服用抗凝药物等具有椎管内麻醉禁忌证者。 两组患者性别构成、年龄、体质量指数、ASA分级、手术时间等一般情况差异无统计学意义(表1)。

表1 两组患者一般资料比较
Tab.1 Comparison of baseline data between two groups of patients $\bar{x}\pm{s}$,n=30
组别 例数 性别 年龄/
男/例 女/例
PCIA组 30 16 14 37±9
PCEA组 30 15 15 38±7
组别 体质量指数/
[kg·(m2)-1]
ASA 手术时间/
min
Ⅰ级/例 Ⅱ级/例
PCIA组 23±2 18 12 45±10
PCEA组 22±3 19 11 43±11

表1 两组患者一般资料比较

Tab.1 Comparison of baseline data between two groups of patients $\bar{x}\pm{s}$,n=30

1.2 麻醉方法

两组患者禁饮、禁食6 h,入手术室前均无术前用药。入手术室后常规监测无创血压(noninvasive blood pressure,NIBP)、脉搏氧饱和度(pulse oxygen saturation,SpO2)、心电图(electrocardio-gram,ECG),开放上肢静脉通路,给予面罩吸氧(6 L·min-1),去枕平卧。术中所用器械均采用同种类型。取侧卧位,常规消毒后,行L3-4间隙穿刺,见脑脊液流出后(腰麻针尾缺口向头端),以15 s·mL-1注入0.5%盐酸布比卡因重比重液(10%葡萄糖注射液1 mL+0.75%盐酸布比卡因2 mL)共2.5 mL,术中硬膜外不再追加药物。调整体位达到合适麻醉平面,摆成膀胱截石位开始手术,术中保持患者清醒。患者出手术室前接一次性PCA输液泵(上海博创科技有限公司)。术中如血压低于基础值的15%时给予麻黄素10~15 mg;心率低于50次·min-1时给予阿托品每次0.25 mg。

1.3 镇痛方法

根据术后不同镇痛模式,完全随机均分为PCIA组和PCEA组,每组30例。PCIA组:术后静脉注射舒芬太尼100 μg+托烷司琼10 mg+0.9%氯化钠注射液100 mL,背景输入剂量为2 mL·h-1,单次PCA量为1 mL,间隔时间15 min;PCEA组:术后硬膜外注射0.179%甲磺酸罗哌卡因+舒芬太尼40 μg+0.9%氯化钠注射液至200 mL,背景输入剂量4 mL·h-1,单次PCA量为2 mL,间隔时间15 min,每日静脉注射托烷司琼5 mg。

1.4 观察指标

观察记录术后6,12,24,48 h的Ramsay镇静评分(Ramsay score,RSS)、视觉模拟疼痛评分(visual analogue pain score,VAS)、舒适评分(body comfort rating scale,BCS)、改良Bromage分级。记录PCA 24、48 h内实际按压次数和有效按压次数。记录术后并发症发生情况,如恶心呕吐、皮肤瘙痒、嗜睡、呼吸抑制(术后监测SpO2<90%)、低血压(收缩压<80 mmHg或下降超过其基础值30%)、导尿管停留时间延长(超过48 h)。

Ramsay镇静评分量表:1分,不安静、烦躁;2分,安静合作;3分,嗜睡,能听从指令;4分,睡眠状态,但可唤醒;5分,呼吸反应迟钝;6分,深睡状态,呼唤不醒。VAS疼痛评分:0~1分,无痛;2~3分,轻度疼痛;4~5分,中度疼痛;>5分,重度疼痛。舒适度评分量表(BCS):0分,持续疼痛;1分,安静时无痛,深呼吸或咳嗽时疼痛严重;2分,平卧安静时无痛,深呼吸或咳嗽时轻微疼痛;3分,深呼吸时亦无痛;4分,咳嗽时亦无痛。改良Bromage分级:0级,无运动阻滞,能自行抬起大腿;1级,不能抬起大腿;2级,不能屈膝;3级,不能屈踝关节。

1.5 统计学方法

采用SPSS 13.0版统计学软件,计量资料以均数±标准差( x ¯ ±s)表示,组间比较采用成组t检验;等级资料比较采用秩和检验,计数资料以率表示,采用χ2检验分析,以 P<0.05为差异有统计学意义。

2 结果
2.1 手术后镇痛效果比较

术后12,24 h时,PCIA组Ramsay镇静评分、VAS评分明显高于PCEA组,BCS评分明显低于PCEA组(P<0.05);术后6 h时,PCIA组Bromage分级明显低于PCEA组(P<0.05),见表2。

表2 两组术后镇痛效果比较
Tab.2 Comparison of analgesic effects between two groups of patients $\bar{x}\pm{s}$,n=30
组别与时间 Ramsay镇静评分/分 VAS/分 BCS/分 Bromage分级/级
PCIA组
术后6 h 2.7±0.5 2.3±0.4 3.0±0.6 0.7±0.2
术后12 h 2.6±0.3 3.4±0.4 2.7±0.5 0.6±0.2
术后24 h 2.4±0.4 3.3±0.5 2.9±0.6 0.5±0.1
术后48 h 2.2±0.1 2.2±0.1 2.2±0.1 0.4±0.1
PCEA组
术后6 h 2.6±0.4 2.2±0.5 3.1±0.7 1.1±0.3*1
术后12 h 2.2±0.2*1 2.4±0.6*1 3.4±0.4*1 0.9±0.3
术后24 h 2.0±0.3*1 2.3±0.3*1 3.5±0.3*1 0.8±0.2
术后48 h 2.1±0.2 2.0±0.2 2.1±0.2 0.7±0.1

与PCIA组比较,*1P<0.05

Compared with PCIA group,*1P<0.05

表2 两组术后镇痛效果比较

Tab.2 Comparison of analgesic effects between two groups of patients $\bar{x}\pm{s}$,n=30

2.2 PCA按压次数的比较

PCIA组术后24,48 h实际按压次数、有效按压次数均明显多于PCEA组(P<0.05)(表3)。

表3 两组PCA按压次数比较
Tab.3 Comparison of PCA press times between two groups of patients $\bar{x}\pm{s}$,n=30
组别与时间 实际按压次数 有效按压次数
PCIA组
术后24 h 5±1 4±1
术后48 h 5±1 4±1
PCEA组
术后24 h 2±1*1 2±1*1
术后48 h 2±1*1 2±1*1

与PCIA组比较,*1P<0.05

Compared with PCIA group,*1P<0.05

表3 两组PCA按压次数比较

Tab.3 Comparison of PCA press times between two groups of patients $\bar{x}\pm{s}$,n=30

2.3 术后镇痛不良反应比较

PCIA组术后恶心、呕吐5例,明显多于PCEA组的2例(P<0.05);两组术后嗜睡、呼吸抑制、低血压、导尿管保留时间延长的发生率均差异无统计学意义(P>0.05)(表4)。

表4 两组术后镇痛不良反应比较
Tab.4 Comparison of adverse reactions of postoperative analgesia between two groups of patients
组别 例数 恶心呕吐 嗜睡 呼吸抑制 低血压 导尿管保留时间延长
% % % % %
PCIA组 30 5 16.7 1 3.3 0 0.0 1 3.3 2 6.7
PCEA组 30 2 6.7*1 1 3.3 0 0.0 1 3.3 2 6.7

与PCIA组比较,*1P<0.05

Compared with PCIA group,*1P<0.05

表4 两组术后镇痛不良反应比较

Tab.4 Comparison of adverse reactions of postoperative analgesia between two groups of patients

3 讨论

吻合器痔上黏膜环切术于1998年由意大利学者Longo首创,21世纪流行于国内,逐步成为中、重度痔的主要治疗手段。随着技术日臻成熟和经验积累,为达到良好的治疗效果,国内术者多将环切层下移至切除部分痔组织[1,2],使吻合口更靠近齿状线。随之而来的是疼痛程度增加,尿潴留发生率亦相应升高。如何减轻PPH术后疼痛成为麻醉医生和外科医生共同关注的问题。

术后镇痛多选用PCA,主要采用静脉和硬膜外镇痛两种模式。PCIA以阿片类药物为主,存在应用剂量增大,不良反应亦随之增加的缺点。PCEA因运动阻滞使其临床应用受到限制。小剂量阿片类药物复合局麻药应用于硬膜外输注,既能增强镇痛效果,又可减少局部麻醉药用量。甲磺酸罗哌卡因是近期应用较广的国产长效酰胺类局麻药,其作用与等摩尔浓度的盐酸罗哌卡因相似,具有良好的运动与感觉分离特性,且药理学作用更稳定,临床应用安全有效。舒芬太尼因强大的镇痛作用,持续时间长,适用于硬膜外自控镇痛[3,4,5,6]

国外日间PPH手术已见相关报道[7],但限于国内医疗环境,目前我院PPH手术仍以住院手术为主。本研究采用0.179%甲磺酸罗哌卡因复合舒芬太尼40 μg硬膜外镇痛显示了良好的镇痛效果,此与国外报道相一致[8,9]。高浓度的局麻药可直接通过血脑屏障作用于中枢,引起一系列并发症[10,11,12,13,14,15],故本研究采用低浓度甲磺酸罗哌卡因复合舒芬太尼镇痛策略。PCIA组发生术后恶心、呕吐的患者明显多于PCEA组(P<0.05),与国内研究相似[16,17,18,19]。两组术后嗜睡、呼吸抑制、低血压、导尿管保留时间延长的发生率差异无统计学意义(P>0.05),可能与本研究采用了较低浓度的局麻药复合舒芬太尼有关。

本研究显示,PCEA用于经吻合器痔上黏膜环切术后镇痛,可提供更好的舒适度,优于PCIA。

The authors have declared that no competing interests exist.

参考文献

[1] 曾山崎,刘宏杰,张伟健.PPH术对混合痔病个体化治疗方法探讨[J].结直肠肛门外科,2010,16(3):168-169.
目的 探讨和研究不同情况下混合痔患者行PPH手术的个体化治疗对策.方法 回顾性分析我院2004年1月至2009年1月应用PPH术治疗混合痔患者191例的临床资料,其中单纯PPH术83例,行PPH合并手术108例.结果 本组患者手术顺利,术后均无并发症,术后疼痛轻,平均住院天数5 d.随访1个月至3年,无复发.结论 混合痔患者个体化治疗方案的选择,不但可以弥补单纯PPH治疗痔的局限性,还拓展了适应范围,同时也可以获得更好的远期疗效.
[本文引用:1]
[2] 刘传连. 从PPH机制上重新定位其适应证[J].结直肠肛门外科,2010,16(2):121-122.
为倡导学术争鸣,营造活跃的学术气氛,推动结直肠肛门外科的发展和繁荣,本刊新增《争鸣与探讨》栏目,以供作者进行学术交流、探讨,欢迎读者参与讨论,踊跃投稿。
[本文引用:1]
[3] TIXIER S,BONNIN M,BOLANDARD F,et al.Continuous patient-controlled epidural infusion of levobupivacaine plus sufentanil in labouring primipraous women:effects of concentration[J].Anaesthesia,20l0,65(6):573-580.
The effects of two different concentrations of epidural levobupivacaine were compared when used to provide analgesia for labour. Primiparous women in spontaneous uncomplicated labour were enrolled in a prospective, randomised and partially double-blinded study. The study solutions were either 0.568 mg.ml 611 levobupivacaine (low concentration group) or 1.136 mg.ml 611 levobupivacaine (high concentration group), with sufentanil 0.45 μg.ml 611 added to both solutions. Epidural analgesia was initiated with 20 ml of the study solution, followed by a standardised algorithm of top-up bolus injections. Epidural analgesia was then continued by self-administered boluses of 5-ml plus a continuous infusion of 5 ml.h 611 . Analgesia was found to be more efficacious in the high-concentration group. The dose of levobupivacaine administered was higher and sometimes overstepping recommended limits in the high concentration group, but with no observed increase in side-effects. The choice between these two concentrations may still be made according to the patient's and the practitioner's preferences. The effects of an intermediate concentration should be studied in the future.
DOI:10.1111/j.1365-2044.2010.06369.x      PMID:20565392      URL    
[本文引用:1]
[4] 闫秀娟,张媛,王晓东,.CYP3A4*1G基因多态性对胃肠外科老年患者舒芬太尼全麻诱导中应激反应的影响[J].中国医院药学杂志,2016,36(16):1392-1396.
目的:研究胃肠外科手术老年患者CYP3A4*1G基因多态性与舒芬太尼对应激反应抑制作用的相关性。方法:择期全麻胃肠外科手术老年患者119例,以焦磷酸测序法检测CYP3A4*1G基因多态性,根据基因型进行分组,比较不同基因型患者插管前后及切皮前后应激反应(收缩压、舒张压和心率)的变化。麻醉诱导方法为依次给予咪达唑仑、舒芬太尼、维库溴铵、依托咪酯。结果:CYP3A4*1G等位基因突变率为20.17%,符合Hardy-Weinberg平衡。将患者分为野生型组、突变型杂合子组和突变型纯合子组,三组患者插管前后的收缩压、舒张压和心率的波动及切皮前后的舒张压的波动的差别无统计学意义(P0.05),而野生型组与突变型杂合子组患者切皮前后的收缩压和心率的波动的差别有统计学意义(P0.05)。结论:CYP3A4*1G基因多态性与舒芬太尼抑制切皮引起的应激反应的强弱有关。
[本文引用:1]
[5] 蒋文军,杨孟昌,徐冰.七氟醚复合舒芬太尼与氯胺酮麻醉对疝气腹腔镜手术患儿的临床效果及血液流变学分析[J].中国医院药学杂志,2016,36(10):838-840.
<p><strong>目的:</strong> 观察比较七氟醚复合舒芬太尼对比氯胺酮全身麻醉在小儿疝气腹腔镜手术中的临床效果及血液流变学变化。<strong>方法:</strong> 将60例行疝气腹腔镜手术的患儿随机分为2组,分别为观察组30例,采用面罩吸入七氟醚复合静脉滴注舒芬太尼进行麻醉;对照组30例,采用氯胺酮肌内注射进行麻醉。观察2组患儿麻醉诱导时间、苏醒时间、手术时间、不良反应情况及麻醉前后患儿血液流变学指标心率(HR)、平均动脉压(MAP)、血氧饱和度(SpO<sub>2</sub>)变化。<strong>结果:</strong> 观察组与对照组相比,观察组麻醉诱导时间、苏醒时间更短,不良反应情况更少,差异存在统计学意义(<em>P</em>&lt;0.05),手术时间差异不存在统计学意义;血液流变学指标HR、MAP、SpO<sub>2</sub> 2组变化差异不存在统计学意义(<em>P</em>&gt;0.05)。<strong>结论:</strong> 应用七氟醚复合舒芬太尼进行小儿疝气腹腔镜手术的麻醉效果更好,具有麻醉诱导时间短,苏醒快,手术时间短,不良反应少的特点,值得临床推广。</p>
[本文引用:1]
[6] 苏跃,孙杰,徐铭军,.分娩镇痛对产后抑郁症发生的影响[J].中华麻醉学杂志,2015,35(3):317-319.
目的 评价分娩镇痛对产后抑郁症发生的影响.方法 单胎头位足月初产妇70例,年龄20~ 35岁,BMI<27 kg/m2,孕龄38~41周,ASA分级Ⅰ级,采用随机数字表法,将其分为2组(n=35):自然分娩组(VD组)和分娩镇痛组(LA组).LA组于宫 口2~3 cm时于L23间隙行脊椎-硬膜外联合穿刺,行脊椎-硬膜外联合分娩镇痛,维持VAS评分<3分.于分娩后42 d进行爱丁堡产后抑郁量表评分,记录抑郁症发生情况.结果 VD组和LA组产后抑郁症发生率分别为40%和17%,LA组低于VD组(P<0.05).结论 分娩镇痛可降低产后抑郁症的发生.
[本文引用:1]
[7] KOSOROK P.Our criteria for PPH procedure in one day surgery practice[J].Tech Coloproctol,2010,14(1):9-11.
Background The aim of this report is to analyse our results and to underline our criteria for day surgery practice. Patients and methods Our patients are selected according to ASA criteria. Occasionally, the patients with some risk factors are selected but only when their concomitant diseases are well controlled. Results We have treated 673 patients with the third and early fourth degree haemorrhoids. We have had patients with several minor problems causing no influence on the success of the procedure. Good haemostasis, preventing postoperative bleeding, is the most important factor. Conclusion Among proctological procedures in haemorrhoid treatment, the PPH technique has firm and well-accepted position even in ambulatory surgery.
DOI:10.1007/s10151-010-0634-8      PMID:20700616      URL    
[本文引用:1]
[8] NIESTERS M,DAHAN A.Pharmacokinetic and pharmaco-dynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain[J].Expert Opin Drug Metab Toxicol,2012,8(11):1409-1417.
ABSTRACT Introduction: Chronic neuropathic pain is a debilitating disease caused by a lesion of the somatosensory nervous system. The N-methyl-D-aspartate receptor (NMDAR) plays an important role in the development of this pain state. Proof of efficacy of NMDAR inhibitors in treating neuropathic pain is limited, with the non-selective NMDAR antagonist ketamine being most effective. Areas covered: This review discusses the efficacy of subanesthetic doses of ketamine in alleviating chronic neuropathic pain, and highlights its pharmacokinetics and dynamics. The reader will understand under which treatment conditions ketamine is most effective, and through which mechanisms ketamine acts to induce long-term pain relief. The reader will gain an understanding of ketamine's complex metabolism and the role of its metabolite norketamine. Possible future alternatives for ketamine are discussed aimed at blockade of the subunit of the NMDAR involved in spinal and supraspinal pain pathways (NR2B). Expert opinion: More proof from good-quality randomized clinical trials on the efficacy of NMDAR inhibitors is required. A major advantage of ketamine therapy is the ability of the molecule to induce rapid and potent antidepressant effects. This is relevant taken the fact that chronic pain and depression are closely linked and are often present in the same patient.
DOI:10.1517/17425255.2012.712686      PMID:22871026      URL    
[本文引用:1]
[9] FEENSTRA P,BRUNSTEINER M,KHINAST J.Prediction of drug-packaging interactions via molecular dynamics(MD)simulations[J].Int J Pharm,2012,431(1/2):26-32.
The interaction between packaging materials and drug products is an important issue for the pharmaceutical industry, since during manufacturing, processing and storage a drug product is continuously exposed to various packaging materials. The experimental investigation of a great variety of different packaging material rug product combinations in terms of efficacy and safety can be a costly and time-consuming task. In our work we used molecular dynamics (MD) simulations in order to evaluate the applicability of such methods to pre-screening of the packaging material-solute compatibility. The solvation free energy and the free energy of adsorption of diverse solute/solvent/solid systems were estimated. The results of our simulations agree with experimental values previously published in the literature, which indicates that the methods in question can be used to semi-quantitatively reproduce the solid-liquid interactions of the investigated systems.
DOI:10.1016/j.ijpharm.2012.03.049      PMID:22521710      URL    
[本文引用:1]
[10] GULCIN U S,YENER O,SAHIN H,et al.The comparison of analgesic effects of various administration methods of diclofenac sodium,transdermal,oral and intramuscular,in early postoperative period in laparoscopic cholecystectomy operations[J].Pak J Med Sci,2014,30(1):96-100.
Objective:The aim of this study was to compare the efficacy of oral, intra muscular and transdermal diclofenac sodium for pain treatment in patients undergoing laparoscopic cholecystectomy, and their effect on postoperative opioid consumption. Methods:Following informed consent, 90 ASA I-II patients scheduled for laparoscopic cholecystectomy were randomized into three groups. Group PO got oral diclofenac sodium 1 hour before the operation, Group IM 75 mg diclofenac sodium intra muscular and Group TD diclofenac sodium patch 6 hours before the operation. Patients were not premedicated. Routine anaesthesia induction was used. After the operation in post anaesthesia care unit tramadol HCl infusion was delivered by intravenous patient controlled analgesia (iv PCA). Ramsey Sedation Score (RSS), Modified Aldrete Score System(MASS) and Visual Analog Scale Pain Score (VAS) was used for postoperative evaluation. Postoperative opioid consumption was recorded. Results:Demographic characteristics, intraoperative and postoperative hemodynamics of the patients were similar between groups. Postoperative VAS were lower at all time points in Group IM and Group TD than in Group PO. Lowest Postoperative RSS were in Group IM and the highest were in Group PO, and the difference between groups was significant. There was no significant difference in Postoperative MASS between groups. Postoperative tramadol consumption was statistically different between groups. Tramadol consumption in Group IM and Group TD was lower than Group PO. Postoperative nausea and vomiting was not observed. Local complications related to transdermal and intra muscular applications was not reported. Conclusion:In patients undergoing ambulatory laparoscopic cholecystectomy, a noninvasive application transdermal diclofenac sodium is as effective as intramuscular diclofenac sodium and can be preferred in postoperative pain treatment.
DOI:10.12669/pjms.301.4140      PMID:24639839      URL    
[本文引用:1]
[11] RIVARD C,DICKSON E L,VOGEL R I,et al.The effect of anesthesia choice on post-operative outcomes in women undergoing exploratory laparotomy for a suspected gynecologic malignancy[J].Gynecol Oncol,2014,133(2):278-282.
61PCEA in gynecologic oncology patients undergoing laparotomy is associated with decreased narcotic use and pain scores.61TAP blocks are associated with decreased narcotic use on the day of surgery, but not on postop days 2–3.
DOI:10.1016/j.ygyno.2014.02.027      PMID:4592284      URL    
[本文引用:1]
[12] 沈隽,李东来,黄海波.舒芬太尼用于胸科手术患者硬膜外与静脉术后镇痛效果与通气功能比较[J].医药导报,2010,29(3):316-318.
目的比较静脉、硬膜外两种镇痛方法对胸部手术后的镇痛效果和通气功能的影响。方法择期胸科手 术患者50例,随机分为静脉镇痛组(Ⅰ组)和硬膜外镇痛组(Ⅱ组),各25例。术后镇痛方法:Ⅰ组持续以3mL·h^-1速率静脉泵注舒芬太尼 3μg·h^-1+自控镇痛(PCA)每次0.5μg(锁定时间20min)。Ⅱ组经硬膜外导管注射单次负荷量舒芬太尼2.5μg后,以2mL·h^-1 速率持续硬膜外泵注0.1%罗哌卡因和舒芬太尼(0.4μg·mL^-1)混合液,PCA每次2mL(锁定时间20min)。术后定时测定心率(HR)、 平均动脉压(MAP)、动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、血氧饱和度(SaO2)值,视觉模拟痛觉评分(VAS)和用力肺活 量(FVC)、第一秒钟用力呼出气量(FEV1)。结果Ⅱ组患者术后3,6和12h的VAS值明显低于Ⅰ组(P〈0.05),FVC和FEV1值及术后 24h的FEV,值均显著大于Ⅰ组(P〈0.05);Ⅰ组患者术后1h的PaO2、SaO2明显低于Ⅱ组(P〈0.05)。结论该硬膜外镇痛法对胸科手术 患者不仅能产生满意的术后镇痛效果,而且有利于患者术后通气功能的恢复。
DOI:10.3870/yydb.2010.03.016      URL    
[本文引用:1]
[13] 赵娜,傅东英,王必超,.两种硬膜外分娩镇痛给药方式效果比较 [J].护理学杂志,2011,26,(20) :36-38.
目的观察两种硬膜外分娩镇痛给药方式对产妇镇痛满意度的影响。方法将60例ASAⅠ~Ⅱ级有分娩镇痛要求的初产妇随机分为Ⅰ组和Ⅱ组各30例,两组均在成功实施硬膜外阻滞后,将硬膜外导管与镇痛泵相连;Ⅰ组设定无背景剂量,Ⅱ组设定背景剂量5 ml/h;均设置单次剂量5 ml,锁定时间15 min。结果两组产妇在分娩镇痛期间的BP、HR、RR、SpO2、胎心率及宫缩强度均在正常范围,各记录时点的VAS评分、不良反应发生率及产妇满意度两组差异无统计学意义(均P0.05);Ⅰ组行PCEA单次剂量追加例数和按压次数均显著多于Ⅱ组(均P0.01),使用罗哌卡因和舒芬太尼药量显著少于Ⅱ组(均P0.01)。结论两种给药方式均能使产妇达到较高满意度,有背景剂量的给药方式接近理想分娩镇痛效果。
DOI:10.3870/hlxzz.2011.20.036      URL    
[本文引用:1]
[14] 胡双燕,仲俊峰,何锐,.右美托咪定复合舒芬太尼静脉镇痛对腹腔镜胃切除患者术后肠功能的影响[J].中国临床药理学与治疗学,2016,21(12):1409-1412.
目的:观察右美托咪定复合舒芬太尼术后静脉镇痛对腹腔镜胃切除患者术后肠功能的影响。方法:择期行腹腔镜胃切除患者60例,术后使用静脉自控镇痛,随机分为两组:右美托咪定组(S组)和右美托咪定复合舒芬太尼组(SD组)。记录两组患者术后第1次肠排气时间、肠功能指数(bowel function index,BFI)、术后静息和咳嗽时疼痛数字评分(numerical rating scales,NRS)、首次使用哌替啶的时间和术后48 h内哌替啶总量、术后不良反应(呼吸抑制、恶心、呕吐)。结果:SD组患者术后第1次肠排气时间为术后(67.2±3.5)h,与S组(73.1±5.3)h相比,差异具有统计学意义(P〈0.05);SD组与S组术后BFI≤28.8的患者分别为26例(86.7%)和19例(63.3%)(P〈0.05);SD组患者术8、16、24、36、48 h静息NRS和术后4、8、16、24、36、48 h咳嗽NRS均显著低于S组(P〈0.05)。SD组患者术后首次使用哌替啶时间为(8.2±2.4)h,与S组(4.3±1.9)h相比,差异具有统计学意义(P〈0.05);SD组与S组哌替啶使用量分别为(70.5±21.9)mg和(105.4±32.2)mg,两组比较,差异具有统计学意义(P〈0.05);术后恶心发生率SD组和S组分别为4例(13.3%)和11例(36.7%),差异具有统计学意义(P〈0.05)。结论:右美托咪定复合舒芬太尼术后镇痛能有效减轻腹腔镜胃切除患者术后疼痛,减少哌替啶的用量,促进患者术后肠功能恢复。
URL    
[本文引用:1]
[15] 涂然,王颖,彭艳华,.芬太尼、舒芬太尼麻醉对心脏直视手术患儿应激和心肌肌钙蛋白I影响的比较[J].中国临床药理学与治疗学,2016,21(4):450-454.
目的:比较舒芬太尼、芬太尼麻醉对心脏直视手术患儿应激和心肌肌钙蛋白I的影响。方法:择期行先天性心脏畸形矫治术的患儿30例,年龄8~36月,体重5.8~14 kg,随机分为芬太尼组和舒芬太尼组,每组15例(n=15),分别采用等效剂量的芬太尼和舒芬太尼静脉复合麻醉。在体外循环前、停机5 min、停机4 h、停机8 h和停机16 h测定血浆皮质醇、乳酸和心肌肌钙蛋白Ⅰ的水平。结果:体外循环前,血浆皮质醇、乳酸和肌钙蛋白Ⅰ水平差异无统计学意义,体外循环后,三项指标有不同程度升高,但舒芬太尼组明显低于芬太尼组。结论:舒芬太尼麻醉用于小儿心脏直视手术,能够更好地抑制应激反应,减轻心肌损伤。
URL    
[本文引用:1]
[16] 冯超群,郭小亮,李学伦.超声引导下胸椎椎旁神经阻滞复合全身麻醉在肝部分切除术中的应用[J].新乡医学院学报,2016,33(4):308-311.
目的 探讨超声引导下胸椎椎旁神经阻滞(TPVB)复合全身麻醉在肝部分切除术中的应用效果.方法 80例择期行肝右叶部分切除术的肝细胞癌患者分为观察组和对照组,每组40例.对照组患者给予喉罩吸入全身麻醉,观察组患者给予超声引导下TPVB复合喉罩吸入全身麻醉;观察2组患者麻醉后加强监护病房(PACU)停留时间、术中及PACU观察期间舒芬太尼使用量、术后48 h疼痛视觉模拟评分(VAS) >4的病例数、术后48 h内患者单次使用自控静脉镇痛(PCIA)次数及术后并发症发生情况.结果 2组患者手术时间、术中出血量、补液量及尿量比较差异均无统计学意义(P>0.05).术前、切皮时、术中30 min时2组患者平均动脉压(MAP)、心率(HR)、血氧饱和度(SpO2)及体温比较差异均无统计学意义(P>0.05);手术结束拔除喉罩后患者Aldrete评分达到出苏醒室标准时观察组患者MAP、HR低于对照组(P<0.05),但2组患者SpO2及体温比较差异无统计学意义(P>0.05).观察组患者PACU停留时间显著短于对照组(P<0.01),观察组患者术中及在PACU停留期间舒芬太尼使用量均显著少于对照组(P<0.01).术后1、6、12 h,观察组疼痛VAS评分>4的患者例数显著少于对照组(P<0.05).在术后0~1、>1~6、>6 ~ 12、>12 ~24及0~48 h,观察组患者单次使用PCIA的次数显著少于对照组(P<0.05,P<0.01).观察组患者术后恶心呕吐及呼吸抑制发生率显著低于对照组(P<0.05).结论 超声引导下TPVB复合喉罩吸入全身麻醉可以减少术中和术后阿片类药物使用量,缩短PACU停留时间,减轻患者术后疼痛,减少术后并发症.
DOI:10.7683/xxyxyxb.2016.04.015      URL    
[本文引用:1]
[17] 兰海涛,王卉,季书彪.麻醉性镇痛药联用在颅内动脉瘤栓塞手术中的效果[J].新乡医学院学报,2015,32(11):1028-1031.
目的观察芬太尼、舒芬太尼分别与瑞芬太尼联用在颅内动脉瘤栓塞手术中的应用效果。方法择期行颅内动脉瘤栓塞手术患者69例,采用随机数字表法随机分为芬太尼组(F组)、芬太尼+瑞芬太尼组(FR组)和舒芬太尼+瑞芬太尼组(SR组),每组23例。所有患者均采用全凭静脉全身麻醉,麻醉诱导:F组和FR组患者静脉注射3μg·kg-1芬太尼,SR组患者静脉注射0.5μg·kg-1舒芬太尼,余依次静脉注射咪达唑仑、丙泊酚、顺苯磺酸阿曲库铵,插管后行间歇正压通气,并调整呼吸参数维持呼气末二氧化碳分压(PETCO2)在30~35 mm Hg(1 mm Hg=0.133 k Pa)。麻醉维持:3组患者均采用微量泵持续泵注丙泊酚6~8 mg·kg-1·h-1、顺苯磺酸阿曲库铵0.1 mg·kg-1·h-1,同时FR组和SR组患者持续泵注瑞芬太尼0.2μg·kg-1·min-1,手术结束前5 min停用顺苯磺酸阿曲库铵、丙泊酚,瑞芬太尼输注至手术结束时,诱导后每60 min F组、FR组患者静脉注射0.1 mg芬太尼,SR组患者静脉注射5μg舒芬太尼。监测麻醉诱导前(T0)、麻醉诱导后(T1)、气管插管后1 min(T2)、术中1 h(T3)、拔管后1(T4)、5 min(T5)时的平均动脉压(MAP)及心率(HR)。记录患者呼吸恢复时间、苏醒时间、拔管时间及拔管后1 min、拔管后10 min时的警觉/镇静(OAA/S)评分,观察不良反应发生情况。结果 3组患者T0时MAP、HR比较差异均无统计学意义(P〉0.05)。F组患者T1时MAP、HR较T0时降低,T2、T4时MAP、HR较T0时增高(P〈0.05);FR组患者T1、T3时MAP、HR较T0时降低,T2、T4时MAP、HR较T0时增高(P〈0.05);SR组患者T1、T2、T3、T4时MAP、HR均较T0时降低(P〈0.05)。FR组患者T3时及SR组患者T2、T3、T4时MAP、HR较F组同时点降低(P〈0.05)。SR组患者T2、T4时MAP、HR比FR组同时点显著降低(P〈0.05)。3组患者呼吸恢复时间及拔管后1、10 min OAA/S评分比较差异均无统计学意义17
DOI:10.7683/xxyxyxb.2015.11.015      URL    
[本文引用:1]
[18] 刘松,陆蓉,黄成泉,.老年骨科患者术后不同模式镇痛的临床研究[J].临床麻醉学杂志,2013,29(10):997-999.
目的探讨不同镇痛模式在老年骨 科患者术后镇痛的应用。方法择期髋关节或股骨手术老年患者120例。根据不同术后镇痛模式,随机分为舒芬太尼组(SF组)、地佐辛组(DZX组)和左布比 卡因组(ZB组),每组40例。术后镇痛模式分别为:SF组:静脉注射舒芬太尼100μg+生理盐水100ml(PCIA);DZX组:静脉注射地佐辛 10mg+生理盐水100ml(PCIA);ZB组:硬膜外注射0.125%左布比卡因+舒芬太尼100μg+生理盐水至100ml(PCEA)。观察记 录术后4、8、20、24、48h的VAS疼痛评分、布氏舒适评分(BCS)、改良Bromage分级。记录PCA 24、48h内实际按压次数和有效按压次数。记录第一次肛门排气时间、恶心呕吐、嗜睡、呼吸抑制、低血压等发生情况。结果术后20、24h时,DZX组 VAS评分明显高于SF组和ZB组(P0.05);术后4、8h时,ZB组Bromage分级明显高于SF组和DZX组(P0.05);三组患者不同时点 BCS评分差异无统计学意义。术后24、48hDZX组实际按压次数、有效按压次数明显多于SF组和ZB组(P0.05)。SF组发生术后恶心呕吐12 例,明显多于DZX组的5例和ZB组的3例(P0.05)。结论老年髋关节或股骨手术患者术后镇痛,0.125%左布比卡因+舒芬太尼100μg硬膜外镇 痛的模式优于静脉注射舒芬太尼100μg或地佐辛10mg。
URL    
[本文引用:1]
[19] 鲁义,屠伟峰,卿朝晖,.静脉与硬膜外自控镇痛对老年髋关节置换术患者术后镇静、舒适度及并发症影响的比较[J].临床麻醉学杂志,2015,31(2):109-112.
目的探讨疼痛VAS评分≤2分时静脉与硬膜外自控镇痛对老年髋关节置换术患者术后镇静、舒适度以及并发症的影响。方法择期行腰-硬联合麻醉下髋关节置换术患者60例,男27例,女33例,年龄≥60岁,BMI 18.5~25.0kg/m2,术后12h的疼痛VAS评分≤2分,静脉自控镇痛(PCIA组)与硬膜外自控镇痛(PCEA组)各30例,采用Ramsay镇静评分(RSS)、舒适度评分(BCS)量表评估术后12、24h患者的镇静及舒适度,并观察术后并发症发生情况。于术后12h检测患者血清TNF-α与IL-6的含量。结果术后12、24hPCEA组的BCS评分分别为(3.37±0.67)和(3.73±0.45)分,明显高于PCIA组的(2.73±1.14)和(3.03±0.85)分(P0.05);RSS评分分别为(2.17±0.53)和(2.03±0.18)分,明显低于PCIA组的(2.70±1.02)和2.40±0.81)分(P0.05)。PCIA组恶心呕吐发生率明显高于PCEA组(P0.05)。术后12h,PCEA组血清TNF-α与IL-6含量明显低于PCIA组(P0.05)。PCEA组术后低血压、导尿管停留时间延长、下肢乏力或麻木的发生率明显高于PCIA组(P0.05)。结论在疼痛VAS评分≤2分时,PCEA可提供更好的舒适度及镇静效果,但增加术后低血压、导尿管停留时间延长等并发症发生率。
URL    
[本文引用:1]
资源
PDF下载数    
RichHTML 浏览数    
摘要点击数    

分享
导出

相关文章:
关键词(key words)
舒芬太尼
罗哌卡因
甲磺酸
镇痛
术后
静脉自控镇痛
硬膜外自控镇痛
痔上黏膜环切术

Sufentanil
Ropivacaine mesylate
Analgesia
postoperative
Patient-controlled intrav...
Patient-controlled epidur...
Procedure for prolapse an...

作者
孔亮
孟秀荣
陈永军
李德刚
李桂英
张建林
纪伟
周洪

KONG Liang
MENG Xiurong
CHEN Yongjun
LI Degang
LI Guiying
ZHANG Jianlin
JI Wei
ZHOU Hong